PD-1 and PD-L1 expression associates with CD4+, CD8+ and FOXP3+ tumor infiltrating lymphocytes related to poor survival in CCRCC [20,23,24]. The gene discussed is FOXP3; the disease is nonpapillary renal cell carcinoma.